These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 20377101)

  • 1. Moyamoya disease: review of the literature and estimation of excess morbidity and mortality.
    Lee S; Lee S; Kim S; Pokorski R
    J Insur Med; 2009; 41(3):207-12. PubMed ID: 20377101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An epidemiological survey of moyamoya disease, unilateral moyamoya disease and quasi-moyamoya disease in Japan.
    Hayashi K; Horie N; Suyama K; Nagata I
    Clin Neurol Neurosurg; 2013 Jul; 115(7):930-3. PubMed ID: 23041378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic stroke in a postpartum patient: understanding the epidemiology, pathogenesis, and outcome of Moyamoya disease.
    Ishimori ML; Cohen SN; Hallegua DS; Moser FG; Weisman MH
    Semin Arthritis Rheum; 2006 Feb; 35(4):250-9. PubMed ID: 16461070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moyamoya disease: case report and literature review.
    Janda PH; Bellew JG; Veerappan V
    J Am Osteopath Assoc; 2009 Oct; 109(10):547-53. PubMed ID: 19861596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features and outcomes in patients with asymptomatic moyamoya disease--from the results of nation-wide questionnaire survey].
    Yamada M; Fujii K; Fukui M
    No Shinkei Geka; 2005 Apr; 33(4):337-42. PubMed ID: 15830539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anorexia nervosa: a 63-year population-based survival study.
    Iacovino JR
    J Insur Med; 2004; 36(2):107-10. PubMed ID: 15301224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for postoperative ischemic complications in patients with moyamoya disease.
    Kim SH; Choi JU; Yang KH; Kim TG; Kim DS
    J Neurosurg; 2005 Nov; 103(5 Suppl):433-8. PubMed ID: 16302615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moyamoya disease: a review.
    Gosalakkal JA
    Neurol India; 2002 Mar; 50(1):6-10. PubMed ID: 11960143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular treatment for moyamoya disease in a Caucasian twin with angioplasty and Wingspan stent.
    Drazin D; Calayag M; Gifford E; Dalfino J; Yamamoto J; Boulos AS
    Clin Neurol Neurosurg; 2009 Dec; 111(10):913-7. PubMed ID: 19815334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features and outcomes of 10 asymptomatic adult patients with moyamoya disease].
    Nanba R; Kuroda S; Takeda M; Shichinohe H; Nakayama N; Ishikawa T; Houkin K; Iwasaki Y
    No Shinkei Geka; 2003 Dec; 31(12):1291-5. PubMed ID: 14719442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term morbidity and mortality risk in Japanese insurance applicants with chronic hepatitis C virus infection.
    Pokorski RJ
    J Insur Med; 2001; 33(1):12-36. PubMed ID: 11317876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic Moyamoya disease: clinical features and outcome after indirect bypass surgery in four French adults.
    Derex L; Doumbé J; Kouamé-Assouan AE; Pelissou-Guyotat I; Morel C; Hermier M; Nighoghossian N; Trouillas P
    J Neurol Sci; 2010 Jan; 288(1-2):92-5. PubMed ID: 19840882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moyamoya Disease: A Review of Clinical Research.
    Hishikawa T; Sugiu K; Date I
    Acta Med Okayama; 2016 Aug; 70(4):229-36. PubMed ID: 27549666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep apnea: a review for life insurance medical directors and underwriters.
    Richie RC
    J Insur Med; 2003; 35(1):36-50. PubMed ID: 14694824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver function tests and mortality in a cohort of life insurance applicants.
    Pinkham CA; Krause KJ
    J Insur Med; 2009; 41(3):170-7. PubMed ID: 20377096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
    Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
    J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Headache in pediatric moyamoya disease: review of 204 consecutive cases.
    Seol HJ; Wang KC; Kim SK; Hwang YS; Kim KJ; Cho BK
    J Neurosurg; 2005 Nov; 103(5 Suppl):439-42. PubMed ID: 16302616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures.
    Khan N; Schuknecht B; Boltshauser E; Capone A; Buck A; Imhof HG; Yonekawa Y
    Acta Neurochir (Wien); 2003 Dec; 145(12):1061-71; discussion 1071. PubMed ID: 14663563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple intracranial aneurysms and moyamoya disease associated with microcephalic osteodysplastic primordial dwarfism type II: surgical considerations.
    Waldron JS; Hetts SW; Armstrong-Wells J; Dowd CF; Fullerton HJ; Gupta N; Lawton MT
    J Neurosurg Pediatr; 2009 Nov; 4(5):439-44. PubMed ID: 19877776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfusion-weighted magnetic resonance imaging in adult moyamoya syndrome: characteristic patterns and change after surgical intervention: case report.
    Wityk RJ; Hillis A; Beauchamp N; Barker PB; Rigamonti D
    Neurosurgery; 2002 Dec; 51(6):1499-505; discussion 1506. PubMed ID: 12445358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.